Hong Kong Stock Movement
Stocks with High Trading Volume in the Industry
Genscript Biotech rose 1.42% based on recent key news:
<ol>
<li>
On September 15, Zhongtai International stated that although medical insurance cost control still impacts the performance of traditional medical service companies in Hong Kong, the government has repeatedly introduced policies to alleviate the funding issues of medical institutions, leading to a year-on-year decline in Genscript Biotech's profits.
</li>
<li>
On September 15, as immediate settlement of medical insurance gradually takes effect across various regions and the introduction of commercial insurance innovative drug catalogs, the operating environment for leading medical institutions is expected to gradually improve.
</li>
<li>
On September 15, the Trump administration announced it would strengthen scrutiny of innovative drug authorization transactions from China, but it will be difficult to implement in the short term. The innovative drug sector performed well, with increased orders in the CXO sector
</li>
</ol>

02587

HEALTHYWAY INC rose 11.10%; Yimai Sunshine rose 4.18%, with a transaction volume of HKD 312 million; Jinxin Fertility rose 1.42%, with a transaction volume of HKD 101 million; Eddie Kong Holdings rose 4.06%, with a transaction volume of HKD 35.38 million; Global Medical rose 0.16%, with a market value of HKD 11.7 billion

Hong Kong Stock Movement: HEALTHYWAY INC up 11.10%